Chiral Technologies Introduces CHIRALPAK® IJ – DAICEL’s Newest Immobilized Chiral Selector

Chiral Technologies Introduces CHIRALPAK® IJ – DAICEL’s Newest Immobilized Chiral Selector offering more flexibility for screening and method development conditions.

West Chester, Pa: Chiral Technologies, Inc. today announces the addition of CHIRALPAK® IJ, its newest immobilized chiral stationary phase (CSP) from DAICEL Corporation. CHIRALPAK IJ is the immobilized version of DAICEL’s popular coated phase, CHIRALCEL® OJ.

“The addition of this new selector demonstrates DAICEL’s continuing commitment to innovation while providing our customers with the tools necessary to address the separation of challenging compounds,” says Lisa Newton, Vice President of Sales at Chiral Technologies, Inc.

CHIRALPAK IJ is a cellulose polymer derivatized with tris(4-methylbenzoate) moieties. Coated phases like CHIRALCEL OJ are susceptible to degradation from incompatible mobile phases while the immobilized CHIRALPAK IJ is:

• optimized for use under both SFC and HPLC conditions
• more chemically resilient than its coated polysaccharide phase, which allows for a longer column lifetime
• compatible with a wider range of mobile phases, which provides more thorough and complete screening and method development conditions

CHIRALPAK IJ is now available and can be found in our Product List located on our website. For more information on CHIRALPAK IJ, visit www.chiraltech.com or check out the What’s NEW section for our newest CHIRALPAK IJ application notes.

###

About Chiral Technologies
Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380 USA
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing and Sales Services
chiral@chiraltech.com
www.chiraltech.com

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – 160, Bd Gonthier d’Andernach – CS 80140
67404 Illkirch Cedex FRANCE
+33 (0) 3 88 79 5200
Brian Freer, Ph.D., Sales and Marketing Manager
cte@chiral.fr
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD
Lab No. 4A, Phase III, IKP Knowledge Park
Genome Valley, Turkapally, Shameerpet, Ranga Reddy Dist.
Hyderabad-500 078, Telangana INDIA
+91-40-2338-3700
chiral@chiral.daicel.com
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.
No. 32, HeXiang Road
Waigaoqiao Free Trade Zone, Post Code 200131
Shanghai, CHINA
+86 21 504 60086
chiral@ctc.daicel.com
www.daicelchiraltech.cn

Konstantine Haralampopoulos named Business Development Director, Daicel GMP Analytical Services and Pharma Standards at Chiral Technologies, Inc.

WEST CHESTER, Pa (April 6, 2020) — Chiral Technologies, Inc. today announced the hiring of Konstantine Haralampopoulos, as the company’s new Business Development Director for DAICEL GMP Analytical Services and Pharma Standards.

For the last several years, Konstantine has been working for SGS, a leader in life science testing, verification and certification solutions, as a Senior Business Development Manager. Prior to SGS, Konstantine worked at McKesson as a Senior Biologics Strategic Account Manager, Henkel as a Global Key Account Manager and Johnson and Johnson as a Sales Specialist/District Manager. For several years, Konstantine was President of his own company, Konfidant. This was a hybrid consultancy company where he provided marketing and field sales expertise to global clientele in highly visible and accountable roles.

In his new role as Business Development Director here at Chiral Technologies, Konstantine will be responsible for working closely with our colleagues at DAICEL Chiral India, DCTI, to support the pharmaceutical industry from development stage to commercial products in the Americas and Europe.

Konstantine received his Bachelor’s Degree in Biological Sciences from the University of Chicago. “Given Konstantine’s highly technical scientific background, his sales experiences and successes, and his extensive industry knowledge, we are confident he will become a strong asset to our sales team,” said Lisa Newton, Vice President, Sales, Chiral Technologies, Inc.

###

About Chiral Technologies, Inc.

Chiral Technologies, Inc., the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation.  Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

Contact for Chiral Technologies:

Lorraine Evangelista, Manager, Marketing and Sales Services

Chiral Technologies, Inc.

800 North Five Points Road

West Chester, PA 19380 USA

(610) 594-2100

(800) 6-CHIRAL

levangelista@cti.daicel.com

www.chiraltech.com

 

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – 160, Bd Gonthier d’Andernach – CS 80140
67404 Illkirch Cedex FRANCE

+33 (0) 3 88 79 5200

cte@cte.daicel.com

www.chiraltech.com

 

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD

Survey No.542/2, IKP Knowledge Park, Turkapally,
Shamirpet Mandal, Medchal-Malkajgiri District,
Hyderabad-500101. Telangana, INDIA
+91 84 1866 0700 or 91 84 1866 0703

chiral@chiral.daicel.com

www.chiraltech.com

 

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.

No. 32, HeXiang Road

Waigaoqiao Free Trade Zone, Post Code 200131

Shanghai, CHINA

+86 21 504 60086

chiral@ctc.daicel.com

www.daicelchiraltech.cn

Daicel logo

DAICEL Joins Partnership to Develop a DNA Vaccine Against SARS-CoV-2

DAICEL Joins Osaka University and AnGes, Inc. in a Partnership to Develop a DNA Vaccine Against SARS-CoV-2

DAICEL Corporation, the parent company of Arbor Biosciences, is providing their innovative drug delivery device, pyro-drive jet injector Actranza™ lab., for use in a joint partnership to develop a DNA vaccine against SARS-CoV-2, currently being conducted by Osaka University and Japanese company AnGes, Inc.

Overview of the Joint Partnership

  • An effort is underway for the development of a prophylactic DNA vaccine for the SARS-CoV-2 virus between Osaka University (Department of Clinical Gene Therapy/Department of Health Development and Medicine), and AnGes. Inc., utilizing AnGes, Inc.’s plasmid DNA platform.
  • The DNA vaccine production process is generally established in a shorter period of time than the production of conventional vaccines, and is being performed by Takara Bio Inc., who has the plasmid DNA production technology and facilities.
  • DAICEL has developed a gene transfer method using the Actranza™ lab. device, and is conducting research for its clinical application with Osaka University (Department of Device Application for Molecular Therapeutics/Department of Health Development and Medicine). This technology enables efficient delivery of plasmid DNA encoding antigen protein directly into cells via intradermal delivery, in order to initiate antibody production in the body.

About DNA Vaccines

DNA vaccines can be produced in a short period of time without pathogenic components. By inoculating a person with DNA plasmid encoding for a specific viral protein of the pathogen, the antigen protein is produced in the body without effects of the virus, while generating an immune response and thus further immunity against the pathogen.

About the Novel Drug Delivery Device Actranza™ lab.

Actranza™ lab. is a needle-free, jet injector driven by the instantaneous power generated from pyro combustion. The high-speed stream of liquid ejected by the device, such as a DNA vaccine, penetrates the skin and disperses directly into intradermal tissue. Because intradermal tissue contains more immunocompetent cells than muscle tissue, animal studies have shown that higher gene expression can be achieved when DNA vaccines are delivered intradermally when compared to intramuscular delivery with conventional needle injections. View details: https://www.daicel.com/en/research/actranza.html

To learn more about Actranza™ lab. contact:
Wanessa Wight, PhD
Arbor Biosciences Product Manager
US Representative for Actranza™ lab. from Daicel
Office: (734) 388-8642
Cell: (734) 773-7359

###

About Arbor Biosciences

Arbor Biosciences, a subsidiary of Chiral Technologies, Inc. (part of Daicel Corporation), is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost effective, user-friendly products to researchers of genetics and synthetic biology. The team at Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.

Chiral Technologies Introduces CHIRALPAK IH

Chiral Technologies Introduces CHIRALPAK® IH – The Newest Immobilized Chiral Selector from DAICEL Corporation

WEST CHESTER, Pa. (March 8, 2018) — Chiral Technologies announces the newest immobilized chiral stationary phase (CSP) from DAICEL, CHIRALPAK® IH. This new CSP, the immobilized version of DAICEL’s popular CHIRALPAK AS, provides greater solvent versatility, robustness, and loading capacity.

The addition of this new selector demonstrates DAICEL’s continuing commitment to innovation and, to providing our customers with the best way to simplify their work and increase their success.

###

About Chiral Technologies
Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at http://www.chiraltech.com/ and http://www.daicelchiraltech.cn/

CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380 USA
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing and Sales Services
chiral@chiraltech.com
http://www.chiraltech.com/

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – 160, Bd Gonthier d’Andernach – CS 80140
67404 Illkirch Cedex FRANCE
+33 (0) 3 88 79 5200
Brian Freer, Ph.D., Sales and Marketing Manager
cte@chiral.fr
http://www.chiraltech.com/

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD
Lab No. 4A, Phase III, IKP Knowledge Park
Genome Valley, Turkapally, Shameerpet, Ranga Reddy Dist.
Hyderabad-500 078, Telangana INDIA
+91-40-2338-3700
chiral@chiral.daicel.com
http://www.chiraltech.com/

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.
No. 32, HeXiang Road
Waigaoqiao Free Trade Zone, Post Code 200131
Shanghai, CHINA
+86 21 504 60086
chiral@ctc.daicel.com
http://www.daicelchiraltech.cn/

MEDIA CONTACT
Stephanie N. Kuhla
(847) ADVANTA
Advanta Advertising Design | Interactive, LLC
skuhla@advantadesigngroup.com

Chiral Technologies launches sub-2 µm immobilized CSPs

Chiral Technologies Launches sub-2 Micron Immobilized Chiral Columns From Daicel Corporation.

WEST CHESTER, Pa. (November 17, 2016) – Chiral Technologies announces the availability of new sub-2 µm immobilized chiral stationary phases (CSP), a first in the industry.

Daicel Corporation has developed the first two products in its new immobilized sub-2 µm polysaccharide selector series. CHIRALPAK® IA-U and CHIRALPAK IC-U have been designed for use with UHPLC systems for ultrafast and efficient separations of enantiomers.

Ultrafast separations of chiral compounds enable rapid high-throughput screening and optimized method development, which leads to a significant decrease in analysis and chemical development time.

“Daicel Corporation continues its commitment to provide new and innovative chiral chromatography products, thereby providing our customers with unique and timely solutions to advance their workflow in cost-effective ways” said Joe Barendt, Ph.D., President of Chiral Technologies, Inc.

###

About Chiral Technologies, Inc.

Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing Services
chiral@chiraltech.com
www.chiraltech.com

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – 160, Bd Gonthier d’Andernach CS 80140
67404 Illkirch Cedex France
+33 (0) 3 88 79 52 00
Brian Freer, Ph.D., Business Marketing Manager
cte@chiral.fr
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD
Lab No. A4, Phase III, IKP Knowledge Park
Genome Valley, Turkapally, Shameerpet, Ranga Reddy Dist.
Hyderabad-500 078, Telangana
+91 40 2338 3700
chiral@chiral.daicel.com
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.
No. 32, HeXiang Road
Waigaoqiao Free Trade Zone
Post Code 200131
Shanghai, China
+86 21 504 60086
chiral@ctc.daicel.com
www.daicelchiraltech.cn

MEDIA CONTACT
Stephanie N. Kuhla
(847) ADVANTA
Advanta Advertising, LLC
skuhla@advantadna.com

Chiral Technologies, Inc. Announces the Promotion of Joseph Barendt to President

WEST CHESTER, Pa. (May 31, 2016) —Chiral Technologies, Inc., part of Daicel Corporation, the global market leader in enantioselective chromatography is pleased to announce the promotion of Joseph M. Barendt, Ph.D. to the position of President. Dr. Barendt has been with the company for 10 years serving as Chief Operating Officer.

“In the 10 years since Joe joined Chiral Technologies, he has worked diligently to ensure the continued success of the company and our global offices. He has played a key role in consolidating our Global Marketing efforts and successfully launched the new Diffinity Genomics business unit,” stated Dieter Heckmann, Executive Officer, Daicel Corporation.

Dr. Barendt earned his Ph.D. in chemistry from the University of Colorado, and his MBA from the Joseph M. Katz School of Business at the University of Pittsburgh.

###

About Chiral Technologies

Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation.  Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

 

 

Chiral Technologies Introduces CHIRALPAK® IG – The Newest Addition to Daicel’s Immobilised Meta Chiral Selectors

WEST CHESTER, Pa. (May 9, 2016) — Chiral Technologies announces the availability of a new immobilised chiral stationary phase (CSP), CHIRALPAK® IG, a meta-substituted phenyl carbamate of amylose. This new selector joins CHIRALPAK IA, CHIRALPAK IB, and CHIRALPAK IC (also Meta selectors) to form the most effective family of four columns for use as a primary screening set.

Our data shows that the combination of CHIRALPAK IG, CHIRALPAK IA, IB, and IC yields the highest success rate of any four immobilised chiral chromatography columns. When used with CHIRALPAK ID, IE, and IF as a complementary set for secondary screening, chromatographers will find excellent chiral separations provided by the robust immobilised columns to ensure the highest success with the longest column lifetime.

The Meta immobilised columns offer mechanistic advantages in chiral recognition, higher success rates using fewer columns, and are known for their robustness and extended column life.

“We are proud to offer this new column to customers as a way to simplify their chiral method development work, and increase their success rate” said Joe Barendt, Ph.D., President of Chiral Technologies, Inc.

Chiral Technologies Europe will showcase CHIRALPAK IG at Analytica 2016 – Hall A1 –  Stand 225.

###

About Chiral Technologies

Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation.  Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing Services
chiral@chiraltech.com
www.chiraltech.com

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – 160, Bd Gonthier d’Andernach – CS 80140
67404 Illkirch Cedex France
+33 (0) 3 88 79 5200
Brian Freer, Ph.D., Sales and Marketing Manager
cte@chiral.fr
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD
Lab No. 4A, Phase III, IKP Knowledge Park
Genome Valley, Turkapally, Shameerpet, Ranga Reddy
Dist. Hyderabad-500 078, Telangana
+91-40-2338-3700
chiral@chiral.daicel.com
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.
No. 32, HeXiang Road
Waigaoqiao Free Trade Zone
Post Code 200131
Shanghai, China
+86 21 504 60086
chiral@ctc.daicel.com
www.daicelchiraltech.cn

MEDIA CONTACT
Stephanie N. Kuhla
(847) ADVANTA
Advanta Advertising Design | Interactive, LLC
skuhla@advantadesigngroup.com

 

 

 

Daicel Corporation announces collaboration between its subsidiary Daicel Chiral Technologies India and Laurus Labs

HYDERABAD, India (December 16, 2014) — Daicel Corporation, the global leader in chiral chromatography, today announced the results of a successful technical collaboration between its Indian subsidiary Daicel Chiral Technologies India (DCTI) and Laurus Labs, a leading API manufacturer in India. DCTI has successfully developed a cost effective commercial scale SMB separation process for a chiral generic drug. The separation process utilizes single solvent elution on a Daicel Chiral Stationary Phase.

“We are happy to collaborate with DCTI, which is located in close proximity of our R & D facility. DCTI has developed an outstanding continuous chromatography process for our API and thus we quickly realized our dream of implementing commercial scale SMB separation technology for our product. Thanks to Daicel innovations in chiral chromatography,” said Dr. Satyanarayana Chava, CEO of Laurus Labs.

“It is rewarding to see that Laurus has a passion to implement SMB technology for commercial production of generic APIs. We are glad to be partnering with Laurus to prove that SMB is also a viable option for generic API production,” said Mr. Dieter Heckmann, Executive Officer, Daicel Corporation, Japan.

“This example suggests that SMB option should be explored to assess the cost benefit analysis over traditional processes,” said Mr. Lakshmi Narayana, Vice President of DCTI. “Our collaboration will continue to generate SMB POC studies for various intermediates and APIs in Laurus’ portfolio.”

About Daicel Chiral Technologies
Daicel Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

###

CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing & Sales Services
chiral@chiraltech.com
www.chiraltech.com

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – Bd Gonthier d’Andernach
BP 80140 – 67404 Illkirch – Cedex
France
00 33 (0)3 88 79 52 00
Brian Freer, Business Manager
cte@chiral.fr
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD
Lab No. 4A, Corridor 1, Phase III, IKP Knowledge Park
Turkapally Village, Shameerpet, Ranga Reddy District
Hyderabad-500078
India
91 40 23383700
Anand Khatavkar, National Manager, Sales & Marketing
chiral@chiral.daicel.com
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.
No. 32, HeXiang Road
Waigaoqiao FreeTradeZone, Post code: 200131
Shanghai, China
86 21 504 60086
chiral@ctc.daicel.com
www.daicelchiraltech.cn

Chiral Technologies Extends Its Line of High-Performance Supercritical Fluid Chromatography Columns

WEST CHESTER, Pa. (March 18, 2014) — Chiral Technologies announced the extension of its line of Daicel high-performance supercritical fluid chromatography (SFC) chiral columns.  These new optimized 3-mm internal diameter columns are packed with 3-micron immobilized or coated chiral stationary phases (CSPs).  The availability of these new SFC columns will help researchers to fully utilize the latest SFC instrumentation.

Research has confirmed the need to develop these new, small particle size columns to be compatible with the latest SFC systems. These columns ensure the highest success rate in SFC method development for enantiomer separations by combining fast analysis time and high resolution.

Daicel polysaccharide CSPs and columns are the most extensively used in analytical and semi-preparative SFC separations.

About Chiral Technologies

Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services.  The North and Latin American markets are served through Chiral Technologies Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation.  Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

###

 CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing & Sales Services
chiral@chiraltech.com
www.chiraltech.com

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – Bd Gonthier d’Andernach
BP 80140 – 67404 Illkirch – Cedex
France
00 33 (0)3 88 79 52 00
Brian Freer, Business Manager
cte@chiral.fr
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD
Lab No. A4, Corridor 1, Phase III, IKP Knowledge Park
Turkapally Village, Shameerpet, Ranga Reddy District
Hyderabad-500078
India
91 40 23383700
Anand Khatavkar, National Manager, Sales & Marketing
chiral@chiral.daicel.com
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.
No. 32, HeXiang Road
Waigaoqiao FreeTradeZone, Post code: 200131
Shanghai, China
86 21 504 60086
chiral@ctc.daicel.com
www.daicelchiraltech.cn

Chiral Technologies Introduces CHIRALFLASH Medium Pressure Liquid Chromatography Columns

MPLC columns packed with immobilised chiral stationary phases

February 27, 2014 — Chiral Technologies announces the availability of  its first medium pressure liquid chromatography (MPLC) columns, CHIRALFLASH, packed with immobilised chiral stationary phases (CSPs), for the separation of enantiomers.

The CHIRALFLASH columns, 30-mm internal diameter and 100-mm length, are packed with Daicel’s 20-µm IA, IC, ID, IE and IF CSPs.  The semi-preparative CHIRALFLASH columns are specifically designed for rapid and low-cost separation of target compounds for exploratory stage processes.

The columns are reusable and are compatible with any commercially available flash chromatography systems.

About Chiral Technologies 

Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services.  The North and Latin American markets are served through Chiral Technologies Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation.  Learn more at www.chiraltech.com, www.chiral.fr, and www.daicelchiraltech.cn.

###  

CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing & Sales Services
chiral@chiraltech.com
www.chiraltech.com

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – Bd Gonthier d’Andernach
BP 80140 – 67404 Illkirch – Cedex
France
00 33 (0)3 88 79 52 00
Brian Freer, Business Manager
cte@chiral.fr
www.chiral.fr

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD
Lab No. 4A, Phase III, IKP Knowledge Park
Turkapally, Shameerpet, Ranga Reddy District
Hyderabad-500078
India
91 40 23383700
Anand Khatavkar, National Manager, Sales & Marketing
chiral@chiral.daicel.com

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.
No. 32, HeXiang Road
Waigaoqiao FreeTradeZone, Post code: 200131
Shanghai, China
86 21 504 60086
chiral@ctc.daicel.com
www.daicelchiraltech.cn